Rucaparib (tartrate) [CAS 773059-22-6]

Rucaparib (AG014699) tartrate is an orally active, potent inhibitor of PARP proteins (PARP-1, PARP-2 and PARP-3) with a Ki of 1.4 nM for PARP1. Rucaparib tartrate is a modest hexose-6-phosphate dehydrogenase (H6PD) inhibitor. Rucaparib tartrate has the potential for castration-resistant prostate cancer (CRPC) research[1][2][3][4].

[773059-22-6]

C23H24FN3O7

473.45

FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1.OC([C@H](O)[C@@H](O)C(O)=O)=O

PARP

PARP1; PARP2; PARP3

10 mM in DMSO

Room temperature